
    
      Self-complementary adeno-associated virus serotype 9 carrying the human SGSH gene under the
      control of a U1a promoter (scAAV9.U1a.hSGSH) will be delivered one time through a venous
      catheter inserted into a peripheral limb vein. A tapering course of prophylactic enteral
      prednisone or prednisolone will be administered for a period of at least two months.
    
  